Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 136th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TLX	TELIX PHARMACEUTICALS LTD	$3.85B	N/A	N/A	N/A	N/A	1.79	2.01	N/A	N/A	N/A
RLMD	RELMADA THERAPEUTICS INC	$397.88M	-47.50%	-44.00%	-29.26%	-49.00%	0.06	29.52	N/A	N/A	N/A
ALLO	ALLOGENE THERAPEUTICS INC	$559.70M	-50.00%	-36.70%	-31.68%	-44.40%	0.26	10.72	100.00%	-3,566.70%	-3,538.66%
ANTX	AN2 THERAPEUTICS INC	$192.08M	-53.50%	-48.60%	-47.67%	-106.80%	0.08	14.32	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$2.32B	-35.90%	-33.30%	-23.55%	3,321.70%	0.06	18.83	N/A	N/A	N/A
NBTX	NANOBIOTIX SA	$1.60B	N/A	-60.90%	-63.66%	-126.50%	-4.84	1.44	100.00%	-459.50%	-234.58%
YDES	YD BIO LTD	$539.11M	6.40%	3.80%	3.40%	10.90%	1.25	5.23	29.60%	24.70%	24.67%
CBIO	CRESCENT BIOPHARMA INC	$548.24M	-99.10%	-86.90%	-99.33%	2,179.90%	0.12	9.66	100.00%	-1,522.70%	-1,504.28%
CRIS	CURIS INC	$1.73M	-1,035.30%	-87.90%	-399.49%	272.40%	3.04	0.49	99.70%	-490.30%	-490.33%
ABUS	ARBUTUS BIOPHARMA CORP	$927.91M	91.00%	82.30%	56.58%	93.20%	0.06	81.42	100.00%	84.20%	84.27%
OKUR	ONKURE THERAPEUTICS INC	$105.29M	-49.00%	-45.80%	-33.99%	4,223.60%	0.04	26.75	N/A	N/A	N/A
AUTL	AUTOLUS THERAPEUTICS PLC	$495.06M	-178.70%	-49.30%	-56.00%	-33.70%	5.59	4.89	15.70%	-238.70%	-202.47%
SLGL	SOL-GEL TECHNOLOGIES LTD	$236.55M	-44.10%	-37.00%	-33.46%	-58.10%	0.12	10.37	100.00%	-968.40%	-968.41%
ADRX	ADARX PHARMACEUTICALS INC	N/A	N/A	N/A	N/A	N/A	-1.39	12.98	N/A	N/A	N/A
MESO	MESOBLAST LTD	$1.93B	-9.90%	-7.40%	-4.78%	-61.40%	0.36	2.44	100.00%	-47.80%	-27.48%
LGND	LIGAND PHARMACEUTICALS INC	$6.19B	20.10%	11.70%	11.41%	15.40%	1.26	31.18	95.40%	67.90%	84.03%
RNAC	CARTESIAN THERAPEUTICS INC	$219.05M	N/A	-48.30%	-53.76%	-109.70%	-3.54	7.48	100.00%	-10,422.50%	-10,848.48%
CGEN	COMPUGEN LTD	$222.60M	42.60%	26.10%	30.45%	156.80%	0.56	5.72	86.90%	47.60%	47.63%
KZIA	KAZIA THERAPEUTICS LTD	$552.63M	-217.80%	-51.20%	-52.23%	207.80%	0.53	2.87	100.00%	-1,200.90%	-1,285.72%
DNTH	DIANTHUS THERAPEUTICS INC	$4.88B	-22.50%	-21.50%	-16.31%	-29.60%	0.04	26.10	100.00%	-10,097.00%	-10,096.95%
ADAG	ADAGENE INC	$215.53M	-32.20%	-20.50%	-19.21%	126.40%	0.31	5.02	100.00%	-220.80%	-221.64%
CRMD	CORMEDIX INC	$618.10M	44.60%	22.70%	28.77%	80.20%	0.96	2.56	82.80%	40.50%	44.60%
ETRA	ELECTRA THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-0.07	7.37	N/A	N/A	N/A
FATE	FATE THERAPEUTICS INC	$285.17M	-65.10%	-41.70%	-55.38%	-42.40%	0.70	4.85	100.00%	-1,941.10%	-1,941.09%
WHWK	WHITEHAWK THERAPEUTICS INC	$212.64M	-53.90%	-50.00%	-43.64%	-80.40%	0.06	17.38	N/A	N/A	N/A
ATRA	ATARA BIOTHERAPEUTICS INC	$80.80M	N/A	-73.00%	-97.59%	-24.10%	-1.57	1.98	91.40%	-269.40%	-223.36%
MANE	VERADERMICS INC	$4.92B	N/A	N/A	N/A	N/A	0.02	70.53	N/A	N/A	N/A
AGIO	AGIOS PHARMACEUTICALS INC	$1.99B	-35.70%	-33.10%	-39.71%	-37.10%	0.08	10.22	92.00%	-418.20%	-419.27%
PHAT	PHATHOM PHARMACEUTICALS INC	$595.43M	N/A	-35.00%	-20.57%	-6.70%	-1.95	1.92	82.90%	-41.30%	-14.87%
TGTX	TG THERAPEUTICS INC	$8.60B	72.30%	33.60%	10.14%	10.30%	1.71	4.27	82.40%	55.20%	17.40%
GERN	GERON CORP	$796.67M	-29.30%	-12.30%	-8.33%	-5.80%	1.37	6.92	93.50%	-33.10%	-18.27%
QTTB	Q32 BIO INC	$283.70M	76.90%	45.20%	30.58%	259.20%	0.09	20.30	100.00%	62.90%	62.87%
OVID	OVID THERAPEUTICS INC	$496.06M	-23.60%	-20.50%	-15.54%	-25.60%	0.11	12.39	100.00%	-2,178.90%	-2,178.90%
MDXG	MIMEDX GROUP INC	$680.70M	2.60%	2.00%	4.06%	10.20%	0.30	5.33	78.80%	1.80%	2.77%
ADCT	ADC THERAPEUTICS SA	$157.03M	N/A	-32.70%	-23.34%	-43.10%	-2.22	3.03	88.90%	-121.80%	-56.61%
INO	INOVIO PHARMACEUTICALS INC	$114.77M	-1,005.80%	-111.10%	-711.67%	528.60%	10.30	1.00	N/A	N/A	N/A
AGEN	AGENUS INC	$445.25M	-38.00%	44.80%	-255.57%	236.40%	-1.90	0.34	99.50%	69.20%	113.88%
PRQR	PROQR THERAPEUTICS NV	$177.72M	-75.20%	-35.80%	-40.98%	-92,967.80%	0.68	3.49	100.00%	-228.20%	-219.51%
BLTE	BELITE BIO INC	$6.56B	-16.90%	-16.60%	-10.07%	-29.10%	0.01	50.02	N/A	N/A	N/A
CHRS	COHERUS ONCOLOGY INC	$182.31M	-183.40%	-42.90%	-106.38%	-562.00%	2.14	1.77	68.90%	-259.40%	-241.58%
NIKI	NIKI BIOSOLUTIONS INC	$3.86M	-6.20%	-7.80%	-8.99%	-8.90%	0.21	0.78	N/A	N/A	N/A
ARWR	ARROWHEAD PHARMACEUTICALS INC	$9.36B	-60.50%	-17.40%	-11.34%	-8.50%	3.54	5.90	100.00%	-47.80%	-30.96%
RCKT	ROCKET PHARMACEUTICALS INC	$284.32M	-5.80%	-4.90%	-1.72%	-3.90%	0.15	9.25	N/A	N/A	N/A
SDEV	STABLECOIN DEVELOPMENT CORP	$165.51M	-205.20%	-156.60%	-98.41%	-178.80%	0.00	29.98	N/A	N/A	N/A
NKTR	NEKTAR THERAPEUTICS	$2.02B	-38.00%	-25.80%	-12.31%	-22.10%	0.21	10.42	100.00%	-287.80%	-231.00%
JANX	JANUX THERAPEUTICS INC	$1.04B	-10.80%	-10.10%	-10.83%	-10.80%	0.09	16.35	100.00%	-427.50%	-427.47%
OCUL	OCULAR THERAPEUTIX INC	$1.73B	-59.90%	-46.00%	-46.62%	-301.30%	0.29	13.11	87.10%	-579.10%	-557.20%
UNCY	UNICYCIVE THERAPEUTICS INC	$126.74M	-88.80%	-59.70%	-65.98%	-1,916.80%	0.35	3.81	N/A	N/A	N/A
ABSI	ABSCI CORP	$1.74B	-59.20%	-52.30%	-48.53%	-91.90%	0.09	10.63	100.00%	-7,756.40%	-7,750.35%
PRTA	PROTHENA CORP PUBLIC LTD CO	$450.74M	-15.00%	-13.20%	-15.24%	622.90%	0.06	25.05	100.00%	-80.70%	-81.33%
IBRX	IMMUNITYBIO INC	$9.36B	N/A	-172.90%	-159.13%	-62.70%	-1.60	5.72	99.30%	-598.60%	-529.60%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$4.59B	-32.60%	-11.90%	-9.47%	-10.60%	3.43	4.80	75.60%	-20.70%	-16.99%
INMB	INMUNE BIO INC	$54.40M	-82.90%	-62.20%	-87.88%	-1,798.40%	0.32	4.04	N/A	N/A	N/A
RNA	ATRIUM THERAPEUTICS INC	$144.03M	N/A	N/A	N/A	N/A	0.31	8.73	N/A	N/A	N/A
ACOG	ALPHA COGNITION INC	$189.69M	-45.30%	-36.10%	-38.82%	-330.50%	0.22	9.03	89.90%	-153.60%	-147.80%
GALT	GALECTIN THERAPEUTICS INC	$394.32M	N/A	-178.00%	14.69%	-34.60%	-1.10	0.10	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$34.60M	-60.30%	-17.90%	-27.54%	-16.10%	1.94	2.11	100.00%	-1,192.90%	-1,192.94%
PBLS	PARABILIS MEDICINES INC	$3.94B	N/A	N/A	N/A	N/A	0.12	17.91	N/A	N/A	N/A
ALXO	ALX ONCOLOGY HOLDINGS INC	$186.67M	-90.30%	-67.30%	-54.42%	-94.30%	0.18	9.71	N/A	N/A	N/A
COAG	HEMAB THERAPEUTICS HOLDINGS INC	$1.52B	N/A	N/A	N/A	N/A	0.03	35.85	N/A	N/A	N/A
CVM	CEL SCI CORP	$31.48M	-202.10%	-100.80%	-136.77%	-127.90%	0.95	1.48	N/A	N/A	N/A
HCWB	HCW BIOLOGICS INC	$3.21M	-639.50%	-85.10%	-57.91%	-47.90%	2.60	0.06	96.40%	-331.10%	-70.32%
SMMT	SUMMIT THERAPEUTICS INC	$13.08B	-168.90%	-141.90%	-131.99%	-296.20%	0.19	6.96	N/A	N/A	N/A
CNTB	CONNECT BIOPHARMA HOLDINGS LTD	$62.47M	-165.40%	-121.60%	-253.19%	-1,254.70%	0.62	2.37	100.00%	-2,336.30%	-2,329.66%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$173.70M	-37.60%	-30.80%	-36.48%	-30.20%	0.25	10.14	92.10%	-29,747.90%	-29,747.89%
DNA	GINKGO BIOWORKS HOLDINGS INC	$805.39M	-60.20%	-26.90%	-31.77%	-24.20%	1.36	4.57	77.70%	-260.00%	-260.49%
VOGX	VOGENX INC	$361.20M	N/A	N/A	N/A	N/A	-1.79	0.44	N/A	N/A	N/A
ROIV	ROIVANT SCIENCES LTD	$26.36B	-6.10%	-5.00%	-2.82%	-3.70%	0.09	16.72	81.20%	-3,535.00%	-1,879.06%
NERV	MINERVA NEUROSCIENCES INC	$159.95M	N/A	-501.50%	-432.73%	-478.00%	-1.39	20.14	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$789.78M	-34.00%	-32.10%	-34.72%	-36.00%	0.07	18.86	N/A	N/A	N/A
ARTV	ARTIVA BIOTHERAPEUTICS INC	$343.70M	-53.90%	-48.20%	-25.65%	-97.90%	0.06	24.16	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$12.46M	-748.10%	-38.70%	-201.69%	109.30%	-40.94	0.99	37.20%	-804.40%	-804.37%
HYFT	MINDWALK HOLDINGS CORP	$64.46M	-133.30%	-77.80%	-162.52%	-237.50%	1.51	1.84	60.80%	-105.20%	-106.95%
AKBA	AKEBIA THERAPEUTICS INC	$245.52M	-93.70%	-8.20%	-5.57%	-36.60%	12.98	1.43	79.60%	-13.50%	-4.80%
VOR	VOR BIOPHARMA INC	$1.08B	-91.60%	154.20%	137.60%	348.90%	-3.40	19.15	N/A	N/A	N/A
NVCT	NUVECTIS PHARMA INC	$668.90M	-184.30%	-105.20%	-306.61%	229.00%	1.46	1.68	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$12.90B	N/A	-61.20%	-197.13%	-31.70%	-1.48	1.23	94.40%	-97.00%	-90.30%
LCTX	LINEAGE CELL THERAPEUTICS INC	$239.76M	-71.10%	-30.90%	-38.23%	-224.90%	0.76	6.61	99.50%	-246.60%	-286.94%
VRXA	VERAXA BIOTECH AG	$185.24M	N/A	-20.00%	-90.29%	-20.20%	-6.13	0.44	66.00%	-284,359.20%	-286,029.75%
NVAX	NOVAVAX INC	$1.78B	N/A	-22.80%	-35.75%	-36.00%	-6.01	2.33	78.60%	-59.90%	-53.99%
PRME	PRIME MEDICINE INC	$560.45M	-188.30%	-59.10%	-86.45%	-58.20%	5.26	3.06	100.00%	-4,613.10%	-4,613.11%
SNDX	SYNDAX PHARMACEUTICALS INC	$1.63B	-372.90%	-39.10%	-29.53%	-26.00%	45.60	6.77	95.80%	-87.50%	-70.71%
RNTX	REIN THERAPEUTICS INC	$68.15M	-153.20%	-117.00%	-89.71%	-1,754.40%	0.20	4.27	N/A	N/A	N/A
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$165.51M	-69.00%	-61.30%	-71.50%	-367.40%	0.14	6.61	83.80%	-548.60%	-548.64%
SPRO	SPERO THERAPEUTICS INC	$69.88M	16.20%	12.60%	17.24%	227.80%	0.19	6.12	100.00%	15.70%	16.26%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$6.36M	-86.50%	-82.00%	-69.60%	3,928.10%	0.08	12.91	66.90%	-201,355.40%	-201,355.37%
ALEC	ALECTOR INC	$208.80M	-531.00%	-44.00%	-69.72%	-67.00%	-21.35	5.26	100.00%	-850.10%	-847.98%
SLBT	SL SCIENCE HOLDING LTD	$1.03B	N/A	-5.30%	-162.64%	-5.40%	0.23	3.05	35.30%	-173.80%	-173.85%
IRD	OPUS GENETICS INC	$412.24M	N/A	-174.90%	-125.83%	-12,171.30%	-8.16	12.19	100.00%	-1,091.80%	-1,089.81%
CNXU	CONEXEU SCIENCES INC	$104.65M	N/A	N/A	N/A	N/A	0.22	5.31	N/A	N/A	N/A
RNXT	RENOVORX INC	$70.85M	-145.60%	-109.80%	-128.13%	3,950.20%	0.28	5.74	84.40%	-621.70%	-621.71%
GENB	GENERATE BIOMEDICINES INC	$1.98B	N/A	N/A	N/A	N/A	0.23	8.30	N/A	N/A	N/A
BCDA	BIOCARDIA INC	$15.59M	-569.40%	-183.20%	-271.81%	531.10%	0.76	2.09	N/A	N/A	N/A
CAI	CARIS LIFE SCIENCES INC	$8.92B	18.80%	9.30%	14.63%	25.90%	1.08	5.53	69.70%	10.60%	15.35%
CNTN	CANTON STRATEGIC HOLDINGS INC	$189.64M	-29.50%	-23.40%	-20.50%	-29.50%	0.24	15.70	100.00%	-6,559.30%	-7,700.14%
PRAX	PRAXIS PRECISION MEDICINES INC	$7.85B	-34.10%	-32.40%	-25.29%	-55.20%	0.04	15.73	N/A	N/A	N/A
CAMP	CAMP4 THERAPEUTICS CORP	$245.37M	-314.10%	-106.40%	-144.37%	2,371.30%	-135.82	4.70	100.00%	-2,543.70%	-2,543.74%
ACET	ADICET BIO INC	$63.94M	-74.90%	-60.90%	-75.87%	-82.00%	0.23	6.71	N/A	N/A	N/A
CING	CINGULATE INC	$71.33M	-238.40%	-128.70%	-117.27%	-1,212.90%	0.41	3.50	N/A	N/A	N/A
PTN	PALATIN TECHNOLOGIES INC	$16.24M	-115.00%	-69.40%	-123.98%	1,125.00%	0.28	4.61	100.00%	-63.50%	-63.49%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: B, Growth: C, Momentum: A, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 48, which is 24 points higher than the biotech industry average of 24.

PBYI passed 15 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 93.66% over the past year, overperforming other biotech stocks by 167 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -38.65% from Puma Biotechnology's current stock price of $9.78.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Precigen (NASDAQ:PGEN)

Precigen (NASDAQ:PGEN) is the #2 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Precigen (NASDAQ:PGEN) is: Value: C, Growth: A, Momentum: A, Sentiment: B, Safety: F, Financials: C, and AI: B.

Precigen (NASDAQ:PGEN) has a Due Diligence Score of 29, which is 5 points higher than the biotech industry average of 24.

PGEN passed 10 out of 33 due diligence checks and has average fundamentals. Precigen has seen its stock return 121.76% over the past year, overperforming other biotech stocks by 195 percentage points.

Precigen has an average 1 year price target of $13.67, an upside of 69.78% from Precigen's current stock price of $8.05.

Precigen stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Precigen, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Beone Medicines (NASDAQ:ONC)

Beone Medicines (NASDAQ:ONC) is the #3 top biotech stock out of 604 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Beone Medicines (NASDAQ:ONC) is: Value: B, Growth: B, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: B.

Beone Medicines (NASDAQ:ONC) has a Due Diligence Score of 28, which is 4 points higher than the biotech industry average of 24.

ONC passed 9 out of 33 due diligence checks and has average fundamentals. Beone Medicines has seen its stock return 9.75% over the past year, overperforming other biotech stocks by 83 percentage points.

Beone Medicines has an average 1 year price target of $418.55, an upside of 14.59% from Beone Medicines's current stock price of $365.27.

Beone Medicines stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Beone Medicines, 81.82% have issued a Strong Buy rating, 18.18% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.33%, which is 3 percentage points higher than the biotech industry average of 2.12%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 4.84%, which is 3 percentage points higher than the biotech industry average of 2.12%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its high dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.59%, which is -1 percentage points lower than the biotech industry average of 2.12%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 48.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks up?

Biotech stocks were up 0.59% in the last day, and down -3.09% over the last week. Stablecoin Development was the among the top gainers in the biotechnology industry, gaining 108.28% yesterday.

Stablecoin Development shares are trading lower. The company announced it is aware of unusual trading activity and that there has been no material development in its business and affairs.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 42.15% in the past year. It has overperformed other stocks in the biotech industry by 115 percentage points.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 80.09% in the past year. It has overperformed other stocks in the biotech industry by 153 percentage points.

3. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Exelixis's stock has gained 44.56% in the past year. It has overperformed other stocks in the biotech industry by 118 percentage points.

Are biotech stocks a good buy now?

64.68% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 63.92% over the next year.

3.04% of biotech stocks have a Zen Rating of A (Strong Buy), 3.69% of biotech stocks are rated B (Buy), 44.9% are rated C (Hold), 36.88% are rated D (Sell), and 11.5% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 9.98x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Precigen (NASDAQ:PGEN)

3. Beone Medicines (NASDAQ:ONC)

1. Oramed Pharmaceuticals (NASDAQ:ORMP)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Exelixis (NASDAQ:EXEL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.